It started with a belief

Octapharma was founded 40 years ago to provide haemophilia patients with a safer, higher-quality factor VIII (FVIII) concentrate.

News & Stories

Check out our latest stories

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

New Nuwiq® study published in the European Journal of Haematology

Raising awareness of immune thrombocytopenic purpura

Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference

Octapharma lectures

IPIC 2023

Octapharma Symposium

ISTH 2023

Under the Spotlight Symposium

ISTH 2023

Under the Spotlight Symposium

Check all our events

Patient Engagement

Octapharma takes an active role in our community

We sponsor and support organisations worldwide.

Learn how we engage with patients

Careers and Jobs

Explore a new world of opportunities

Our people source, distribute and invent medicines that transform patients' lives. Join our family and make a difference.

Working with Octapharma